Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients With Stage I or IIA Mycosis Fungoides (MF)

NCT00168064 is registered in ClinicalTrials.gov with Yaupon Therapeutics as lead sponsor.

NCT NCT00168064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients With Stage I or IIA Mycosis Fungoides (MF)
Lead sponsor
Yaupon Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
August 31, 2011
Enrollment
260 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

mycosis fungoides